These studies argue that activation of c‐Abl plays a critical role in the formation of pathological α‐synuclein species, inhibition of the protective effects provided by parkin, and in the evolution of the neurodegenerative disease process in PD. This evidence concerns the gene PRKN and neurodegenerative disease.